BioCentury
ARTICLE | Financial News

Relay runs away with $400M series C on back of protein conformation platform

December 20, 2018 12:00 PM UTC

Protein motion company Relay Therapeutics Inc. (Cambridge, Mass.) raised $400 million in an untranched series C led by new investor SoftBank Vision Fund. Relay President and CEO Sanjiv Patel told BioCentury the round will provide multiple years of runway and allow Relay to move several of its lead compounds into first-in-human testing, as well as expand beyond oncology.

Patel said the potential applicability of Relay's platform to diseases outside of cancer is one of the reasons it was able to close such a large round. ...

BCIQ Company Profiles

Relay Therapeutics Inc.